Memantine - Communication Study
NCT00624026
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
107
Enrollment
INDUSTRY
Sponsor class
Conditions
Alzheimer's Disease
Interventions
DRUG:
Memantine-HCl
Sponsor
Merz Pharmaceuticals GmbH